ARCHIVES

In Setback For Generics, Court Overturns FDA.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

Montana Drug Salesman Pleads Guilty to Selling Counterfeit Avastin

July 25, 2013

Ethics Commission To Continue Consideration Of Compensation For Injured Research Subjects

June 20, 1980

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

October 25, 2013

NCI Cooperative Group, Cancer Center Trials Listed

June 29, 2007

Emory’s Winship Cancer Institute Wins NCI Cancer Center Designation

April 17, 2009

Centers Settle Into New Home, Face Old Problem; Five May Lose Grants, No Reprogramming Seen

November 17, 1989